A day after the news broke that Assurant Health Insurance would no longer cover the drug Truvada as pre-exposure prophylaxis (PrEP) to prevent contracting HIV, the company has reversed that decision. Mary Hinderliter, Assurant Health vice president of communications emailed LGBT Weekly today with the following statement, “We are reversing our decision and will be…
A national health insurance campany has announced that it will no longer cover the drug Truvada as pre-exposure prophylaxis (PrEP) to prevent contracting HIV. The insurance company, Assurant Health, have notified customers who had been taking Truvada (comprising the antiretrovirals tenofovir and emtricitabine) as PrEP, reports POZ.com. The insurer has stated that it would end…
Last month, the Centers for Disease Control published guidelines for the use of Pre-exposure Prophylaxis (PrEP) in the prevention of HIV transmission. Since then, discussions about the safety and utility of PrEP have gone from theoretical debates in the research and public health community to the Facebook pages of potential patients with concrete concerns. To…
Health care providers should consider advising the use of anti-HIV drugs by uninfected patients who are at substantial risk of infection, according to new clinical guidelines, released by Centers of Disease Control and Prevention (CDC). PrEP, or pre-exposure prophylaxis, could reduce HIV infection rates. When taken daily as directed, PrEP can reduce the risk of…
SAN DIEGO – Since its FDA approval for use in HIV prevention in July 2012, pre-exposure prophylaxis (PrEP) is quickly becoming a new way to prevent HIV infection. But what is PrEP? How does it work? And how can you access it? Monday, April 14, at 6 p.m., the UC San Diego AntiViral Research Center…
